Related Experiment Videos
The green evolution of psychotropic drugs
1NeuroBiz Consulting & Communications, Castres, France. mike.briley@neurobiz.com
Current Opinion in Investigational Drugs (London, England : 2000)
|May 22, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The management of depression: An international naturalistic survey.
International journal of psychiatry in clinical practice·2014
Five years experience of prescribing milnacipran: An interview with Didier Papeta (Head of Psychiatry, General Military Hospital, Brest, France).
International journal of psychiatry in clinical practice·2014
The noradrenergic symptom cluster: clinical expression and neuropharmacology.
Neuropsychiatric disease and treatment·2011
The importance of norepinephrine in depression.
Neuropsychiatric disease and treatment·2011
The increasing burden of depression.
Neuropsychiatric disease and treatment·2011
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors.
Neuropsychiatric disease and treatment·2010
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
The Timing and Characteristics of Supplemental Indications for Medicines.
The American journal of managed care·2026
Therapeutic effect of Fuzheng Yixin decoction on cardiac insufficiencythe soluble guanylyl cyclase-cyclic guanosine monophosphate-protein kinase G pathway in a doxorubicin-induced dilated cardiomyopathy rat model.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
Shaofu Zhuyu decoction can inhibit the progression of endometriosis fibrosis through the transforming growth factor-β1/ smads signaling pathway mediated by 5' adenosine monophosphate-activated protein kinase.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
Baihe Dihuang decoction activates cannabinoid type 2 receptor to regulate microglial polarization and alleviate anxiety-like behavior in chronic restraint stress mice.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
Real-World Treatment Patterns and Clinical Outcomes with Cyclosporine 0.1% in Semifluorinated Alkane for Dry Eye Disease.
Clinical ophthalmology (Auckland, N.Z.)·2026